Patent applications published 21 April 2010
Patent applications taken from the weekly European Patents Bulletin
- Methods and formulations for reducing and inhibiting the growth of the concentration of microbes in water-based fluids and systems used with them
Dow Global Technologies 2175721*
- Patient selection and therapeutic methods using markers of prostaglandin metabolism
Tragara Pharmaceuticals 2175722*
- Methods and compsns for treating schizophrenia using antipsychotic combination therapy
Medivation Neurology 2175724*
- Quinazolinone T-type calcium channel antagonists
Merck Sharp & Dohme 2175725*
- Compsns including androgen receptor degradation (ARD) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss
AndroScience 2175726*
- A crystalline synthetic intermediate for preparation of a DPP-IV inhibitor and method of purification thereof
Phenomix 2175727*
- Sodium channel inhibitors
Icagen 2175728*
- Aqueous compsn for inactivating sporulated and/or non-sporulated coccidian parasites
Ecolab 2175729*
- GLP-1-FC fusion protein formulation
Eli Lilly 2175834*
- Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery
Georgetown University 2175835*
- Liposome compsn
Invenció-21 Gyógyhatású Készitményeket Gyártó 2175836*
- Micro-particles, blood substitute and method for forming same
Chaité-Universitätsmedizin Berlin 2175837*
- An inhalable medicament
Norton Healthcare 2175838*
- Controlled release pharmaceutical compsn of tolperison hydrochloride
Richter Gideon Nyrt 2175839*
- Pharmaceutical compsns comprising ropinirole
Dr Reddy’s Laboratories Ltd; Dr Reddy’s Laboratories Inc 2175840*
- Osteopontin nanoparticles system for drug delivery
Aarhus Universitet 2175841*
- Multilayered vitamin complex tablet containing ubicarenone
Choongwae Pharma 2175842*
- Extended release compsns comprising tolterodine
Inventia Healthcare 2175843*
- Substituted fluoroethyl ureas as alpha 2 adrenergic agents
Allergan 2175844*
- New combination for use in the treatment of inflammatory disorders
Cardoz 2175845*
- Edible fat compsn for enhancing bone strength
Enzymotec 2175846*
- Cyclodextrin-based nanosponges as a vehicle for antitumoral drugs
Sea Marconi Technologies Di Vander Tumiatti 2175847*
- Therapeutic uses of cannabigerol
GW Pharma 2175848*
- Treatment of melanoma
E-Therapeutics 2175849*
- Methods for treating anxiety
Allergan 2175850*
- Biofilm treatment
Oral Health Australia 2175851*
- N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases
Zetia 2175853*
- Methods of treating metabolic syndrome using dopamine receptor agonists
VeroScience 2175853*
- Improved method for the synthesis of substituted formylamines and substituted amines
University of North Dakota Research Foundation 2175854*
- Stable pharmaceutical compsn of a water-soluble vinorelbine salt
Pierre Fabre Medicament 2175855*
- Novel process for preparing highly pure levocetirizine and salts thereof
Chemagis 2175856*
- Crystalline form of (E) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino-2-pyrimidinyl]amino]benzo-nitrile
Tibotec Pharmaceuticals 2175857*
- Pharmaceutical compsns and methods of treating dry eye disorders
Pfizer 2175858*
- Fused heteroaryl pyridyl and phenyl benzenesulfonamides as CCR2 modulators for the treatment of inflammation
ChemoCentryx 2175859*
- NR4A agonists (6-mercaptopurine) for inhibition of non-ocular scarring
Renovo 2175860*
- Pharmaceutical combination of NSAID and prostaglandin compound
Sucampo 2175861*
- Amino acid vitamin ester compsns for controlled delivery of pharmaceutically active compounds
IDEXX Laboratories 2175862*
- Substituted nucleoside derivatives with antiviral and antimicrobial properties
Eastern Virgina Medical School 2175863*
- Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages
Laclede 2175864*
- Controlled release interferon drugs and treatment of HCV infection using same
Biolex Therapeutics 2175865*
- Novel one step process for preparing cross-linked poly(allylamine) polymers
Chemo Ibérica 217866*
- Method and device for maintaining a constant pH value for a medical liquid during the dispensing thereof from a container
Fresenius Medical Care Deutschland 2175867*
- Methods and compsns for treating neural degeneration
SanBio 2175868*
- Repair of lesions in cartilage and bone using a chondro-regulative matrix
University of Bern 2175869*
- Antibiotic compsns containing essential oils, prophylaxis and treatment of nosocomial diseases
Aroma Technologies 2175870*
- A synergistic herbal compsn for treatment for rheumatic and musculoskeletal disorders
Council of Scientific and Industrial Research, India 2175871*
- Thrombomodulin for increasing reperfusion and preventing blood vessels obstruction
Paion Deutschland 2175872*
